Market closed

10x Genomics/$TXG

14:30

16:10

17:45

19:25

21:00

1D1W1MYTD1Y5YMAX

About 10x Genomics

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Ticker

$TXG

Sector

Health Care

Trading on

NASDAQ

Industry

Life Sciences Tools & Services

Headquarters

Pleasanton, United States

Employees

1,259

Website

www.10xgenomics.com

10x Genomics Metrics

BasicAdvanced

$1.9B

-

-$1.53

1.85 -

Price and volume

Market cap

$1.9B

Beta

1.85

52-week high

$51.22

52-week low

$12.95

Average daily volume

1.6M

Financial strength

Current ratio

4.899

Quick ratio

3.973

Long term debt to equity

10.578

Total debt to equity

11.881

Interest coverage (TTM)

-14,069.17%

Management effectiveness

Return on assets (TTM)

-11.19%

Return on equity (TTM)

-24.87%

Valuation

Price to revenue (TTM)

2.986

Price to book

2.63

Price to tangible book (TTM)

2.71

Price to free cash flow (TTM)

75.088

Growth

Revenue change (TTM)

6.56%

Earnings per share change (TTM)

-20.65%

3-year revenue growth (CAGR)

11.10%

3-year earnings per share growth (CAGR)

-28.50%

What the Analysts think about 10x Genomics

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for 10x Genomics stock.

10x Genomics Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

10x Genomics Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

10x Genomics News

AllArticlesVideos

These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results

Benzinga·3 months ago

10x Genomics, Inc. (TXG) Q3 2024 Earnings Call Transcript

Seeking Alpha·3 months ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $TXG

$

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for 10x Genomics stock?

10x Genomics (TXG) has a market cap of $1.9B as of January 15, 2025.

What is the P/E ratio for 10x Genomics stock?

The price to earnings (P/E) ratio for 10x Genomics (TXG) stock is 0 as of January 15, 2025.

Does 10x Genomics stock pay dividends?

No, 10x Genomics (TXG) stock does not pay dividends to its shareholders as of January 15, 2025.

When is the next 10x Genomics dividend payment date?

10x Genomics (TXG) stock does not pay dividends to its shareholders.

What is the beta indicator for 10x Genomics?

10x Genomics (TXG) has a beta rating of 1.85. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.